Doximity, Inc.

NYSE DOCS

Doximity, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024

Doximity, Inc. Capital Expenditure is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Doximity, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -5.08 M, a 34.19% change year over year.
Doximity, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -7.73 M, a -98.13% change year over year.
Doximity, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -3.90 M.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NYSE: DOCS

Doximity, Inc.

CEO	Mr. Jeffrey A. Tangney
IPO Date	June 24, 2021
Location	United States
Headquarters	500, 3rd Street
Employees	827
Sector	Healthcare
Industries Telehealth Biotechnology Drugstores & Retail Pharmacies Internet Services & Media Medical Instruments Pharmaceuticals Social Media Software-as-a-Service (SaaS)

Description

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Key trends

Past 5 years